search for




KCI

Crossref

Cross mark

Cited-by

Fundref

TDM

View (582) Download (4779) CrossRef (3)
Current Status of Smoking Cessation Program in Foreign Countries
Journal of the Korean Society for Research on Nicotine and Tobacco 2016; 7(2): 53-60
Published online July 15, 2016
© 2016 The Korean Society for Research on Nicotine and Tobacco.

Eun Young Choi1, Hong-Jun Cho2, Jung-Ah Lee2, Jin Yong Lee3, Hye-Min Jung4, Minsu Ock1, Hyeon-Jeong Lee1, Woo-Seung Son1, Min-woo Jo1*

1Department of Preventive Medicine, College of Medicine, University of Ulsan, 2Department of Family Medicine, Asan Medical Center, College of Medicine, University of Ulsan,3Public Health Medical Services, Seoul National University Boramae Medical Center, 4Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea
Received May 10, 2016; Revised June 15, 2016; Accepted June 18, 2016.
 Abstract
Smoking cessation treatment using drugs, such as bupropion and varenicline, is an effective approach for helping smokers to stop smoking. According to the Framework Convention on Tobacco Control, many countries have established smoking cessation treatment programs in order to support smokers both financially and non-financially. This article summarizes the current status of smoking cessation treatment program in selected countries and suggests future strategies in Korea. In the US, both social and private insurance companies have provided smoking cessation programs as preventive services without copayment, according to the Patient Protection and Affordable Care Act. The UK NHS provides pharmaceutical treatments and behavioural support for all tobacco users. In 2006, social insurance of Japan began to benefit drug treatments for smokers in outpatient clinics. Chinese Taipei also provides a clinic-based, smoking cessation service which includes both counseling and pharmaceutical treatment. In British Columbia, Canada, all smokers can join in the state's smoking cessation program which provides nicotine replacement therapy, bupropion or varenicline for 12 weeks once a year. Australia covers the benefit of nicotine patch, bupropion and varenicline for smoking cessation, according to the Pharmaceutical Benefit Scheme. Many developed countries have provided smoking cessation programs using bupropion and varenicline without a copayment. The National Health Insurance Service of Korea began to subsidize the counselling fee and drug cost of smoking cessation treatment in 2015. In order to develop and improve this smoking cessation program, the Korean government should benefit from the experience of other countries.
Keywords : Smoking cessation; Treatment; Insurance benefit; Current status
References
  1. USDHHS. The Health Consequences of Smoking — 50 Years of Progress: A Report of the Surgeon Gene ral. U.S. Department of health and human services; 2014.
  2. Jung KJ, Yun YD, Baek SJ, Jee SH, Kim IS. Smoking-Attributable Mortality among Korean Adults. Journal of The Korea Society of Health Informatics and Statistics 2013; 38: 36-48. (Korean)
  3. Chung AY. Drinking, smoking, obesity cause W23 tril. in socioeconomic costs. The Korea Times. 2016 Jan 4. Korean. [cited 2016 Jun 23]
    Available from: http://www.koreatimes.co.kr/www/news/nation/2016/01/116_194599.html
  4. OECD Health Statistics 2015 [Internet]. [cited 2016 Jun 23].
    Available from: http://www.oecd.org/els/health-systems/health-data.htm
  5. Song T, Choi J. The effect of on-line smoking cessation program. Health and Social Welfare Review 2006; 26: 37-67.
  6. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD:U.S. Department of Health and Human Services. Public Health Service. May 2008.
  7. Stead LF, Bergson G, Lancaster T. Physician advice for smo-king cessation. Cochrane Database Syst Rev 2008; (2): CD000165.
    Pubmed
  8. Reus VI, Smith BJ. Multimodal techniques for smoking cessa-tion: a review of their efficacy and utilisation and clinical prac-tice guidelines. Int J Clin Pract 2008; 62: 1753-68.
    Pubmed CrossRef
  9. WHO. 2014 Global Progress report on implementation of the WHO Framework Convention on Tobacco Control [Internet]. WHO Framework Convention on Tobacco Control. [cited 2015 Jun 30]
    Available from: http://www.who.int/fctc/reporting/2014globalprogressreport.pdf?ua=1
  10. U.S. Preventive Services Task Force. The Guide to Clinical Preventive Services 2014: Recommendations of the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality;2014.
  11. Centers for Disease Control and Prevention. Coverage for Tobacco Use Cessation Treatments[Internet]. Atl anta, GA; 2014. [cited 2015 Jun 28]
    Available from: http://www.cdc.gov/tobacco/quit_smoking/cessation/coverage/pdfs/coverage_tobacco_508_new.pdf
  12. American Lung Association. Helping Smokers Quit 2014 [Internet]. [cited 2015 July 9]
    Available from: http://www.lung.org/assets/documents/tobacco/helping-smokers-quit-2014.pdf
  13. Kofman M, Dunton K, Senkewic z MB. Implementation of tobacco cessation coverage under the Affordab le Care Act: Understanding how private health insurance policies cover tobacco cessation treatments. Washington D.C: Georgetown University Health Policy Institute;2012[Internet]. [cited 2015 May 18]
    Available from: http://tfk.org/coveragereport/
  14. National Centre for Smoking Cessation and Training. Local stop smoking services service and delivery guidance 2014 [Internet]. [cited 2015 May 18]
    Available from: http://www.ncsct.co.uk/usr/pub/LSSS_service_delivery_guidance.pdf
  15. McEwen A, West R. Smoking cessation activities by general practitioners and practice nurses. Tobacco Control 2001; 10: 27-32.
    Pubmed KoreaMed CrossRef
  16. Nakamura M. Health insurance coverage for smoking cessation treatment in Japan: current status and future issues. Nihon rinsho. Japanese journal of clinical medicine 2013; 71: 499-505.
    Pubmed
  17. Nakamura M, Mroita T, Oshima A. Increasing needs of national policy for nicotine dependence treatments as a part of tobacco control. Cancer prevention research 2006; 11: 85-8.
  18. Nakamura M. Challenge of nicotine dependence treatment. 32nd World Congress of Internal Medicine; 2014 Oct 24-28; Seoul, Korea.
  19. Hiroki T. The impact of insured tobacco dependence treatment on tobacco control policy and smoking prevalence. Korea and Japan Joint Symposium; 2013 June 14; Seoul, Korea.
  20. Taiwan Tobacco Control Annual Report 2014 [Internet]. [cited 2015 May 20]
    Available from: http://www.hpa.gov.tw/English/file/ContentFile/201502140516082231/2014_Taiwan%20Tobacco%20Control%20Annual%20Report_eng.pdf
  21. Chang FC, Hu TW, Lin M, Yu PT, Ch ao KY. Effects of financing smoking cessation outpatient services in Taiwan. Tobacco Control 2008; 17:183-9.
    Pubmed CrossRef
  22. Strong Foundation, Renewed Focus - An Overview of Canada’s Federal Tobacco Control Strategy 2012-17 [Internet]. Health Canada. [cited 2015 Apr 28].
    Available from: http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/fs-sf/index-eng.php
  23. BC Smoking Cessation Program[Internet]. British Columbia. [cited 2016 July 8].
    Available from: http://www2.gov.bc.ca/gov/topic.page?id=8CC17D1F894140748D740853F361D798#introduction
  24. Scollo, MM and Winstanley, MH. Tobacco in Australia: Facts and issues [Internet]. Melbourne: Cancer Co uncil Victoria; 2015. [cited 2015 Apr 23]
    Available from: www.TobaccoInAustralia.org.au
  25. Supporting smoking cessation: a guide for health professionals [Internet]. Melbourne: The Royal Australian College of General Practitioners, 2011 [updated 2014 July; cited 2015 Apr 23].
    Available from: http://www.racgp.org.au/download/Documents/Guidelines/smoking-cessation.pdf